Results

Total Results: 543 records

Showing results for "anticoagulant prophylaxis".

  1. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/836840/psn-pdf
    April 22, 2021 - to patients and how to administer VTE prophylaxis. … Understand barriers to VTE prophylaxis at the institution. … clinical decision support tool for prophylaxis for venous thromboembolism in trauma. … Venous Thromboembolism Prophylaxis (eCQM). … clinical decision support tool for prophylaxis for venous thromboembolism in trauma.
  2. psnet.ahrq.gov/web-mm/hidden-heparins-hit-happens
    March 27, 2024 - warfarin is introduced in a patient with HIT and typically begins within days of starting the oral anticoagulant … Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysis. … Description Indication Dosing Comment Argatroban Synthetic direct thrombin inhibitor Prophylaxis … Related Resources WebM&M Cases Direct Oral Anticoagulants … See More About The Topic Hospitals Physicians Risk Managers Medicine Anticoagulants
  3. psnet.ahrq.gov/web-mm/comanagement-whos-charge
    July 01, 2011 - Who is responsible for routine patient safety measures, such as deep venous thrombosis prophylaxis? … Because of the risk of central nervous system bleeding, anticoagulant use is a shared responsibility—hospitalists … always contact neurosurgery physicians before starting antiplatelet or anticoagulant agents.
  4. psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.68_slideshow.ppt
    July 01, 2004 - Referenced 4 PROWESS Exclusion Drotrecogin alfa has anticoagulant properties, so patients at high … beta-blockers for coronary artery disease ACE inhibitors for congestive heart failure Pharmacologic prophylaxis
  5. qualityindicators.ahrq.gov/Downloads/Resources/Case_Studies/Johns_Hopkins_Case_Study.pdf
    August 01, 2019 - focuses on the identification of risk factors for VTE and ensuring that patients receive the appropriate prophylaxis … The Collaborative identified service-specific champions, and investigated strategies to improve VTE prophylaxis … The tool requires patient risk stratification and generates an algorithm for administration of prophylaxis … Current improvement efforts include compliance with ordering and administration of appropriate prophylaxis
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - 2 A variety of strategies to prevent VTE are available, including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis, within and between classes of VTE prophylaxis modalities, and … duration of VTE prophylaxis in patients undergoing these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE prophylaxis versus no VTE prophylaxis did not provide strong evidence … low SoE data on the comparative effectiveness of aspirin or mechanical devices with LMWH or other anticoagulants
  7. effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - 2 A variety of strategies to prevent VTE are available, including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis, within and between classes of VTE prophylaxis modalities, and … duration of VTE prophylaxis in patients undergoing these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE prophylaxis versus no VTE prophylaxis did not provide strong evidence … low SoE data on the comparative effectiveness of aspirin or mechanical devices with LMWH or other anticoagulants
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - 2 A variety of strategies to prevent VTE are available, including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis, within and between classes of VTE prophylaxis modalities, and … duration of VTE prophylaxis in patients undergoing these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE prophylaxis versus no VTE prophylaxis did not provide strong evidence … low SoE data on the comparative effectiveness of aspirin or mechanical devices with LMWH or other anticoagulants
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - 2 A variety of strategies to prevent VTE are available, including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis, within and between classes of VTE prophylaxis modalities, and … duration of VTE prophylaxis in patients undergoing these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE prophylaxis versus no VTE prophylaxis did not provide strong evidence … low SoE data on the comparative effectiveness of aspirin or mechanical devices with LMWH or other anticoagulants
  10. effectivehealthcare.ahrq.gov/products/thromboembolism-update/research-protocol/
  11. psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.14_slideshow.ppt
    May 01, 2003 - Preventing Catheter-Related Thrombosis Low molecular weight heparin No clinical trials for prophylaxis
  12. ce.effectivehealthcare.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.
  13. www.cpsi.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.
  14. www.cahps.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.
  15. talkingquality.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.
  16. patientregistry.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.
  17. ahrqpubs.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.
  18. monahrq.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.
  19. healthcare411.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.
  20. cahps.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.